DaVita

DVA · NYSE

$175.35−$11.65 (−6.23%)TodayMarket closed · Oct 20, 7:48 PM ET

Prev close $187.00

About DVA

DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

Employees: 78,000
Headquarters: Denver, Colorado
Listed: Oct 31, 1995
Sector: Health Care
Industry: Health Care Providers & Services
Website: davita.com

Leadership

DaVita executives
Name	Title	Since	Age
Pamela Arway	—	—	71
Javier Rodriguez	—	2000	54
Joel Ackerman	—	—	60
Stephanie Hendrickson	—	—	—
Christopher Berry	—	—	50
James Hearty	—	—	56
David Maughan	—	—	48
Kathleen Waters	—	—	57
Barbara Desoer	—	—	72
Jason Hollar	—	—	52
Gregory Moore	—	—	60
Dennis Pullin	—	—	65
Adam Schechter	—	—	60
Wendy Schoppert	—	—	58
Phyllis Yale	—	—	67
Nic Eliason	—	2022	—

Revenue by product and region

Fiscal year ended Dec 31, 2025: $13.64B total revenue

By product

U S Dialysis$11.73B86.0%
Other - Ancillary services$1.91B14.0%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

DaVita suppliers and customers
Company	Relationship	Country	Correlation
Fresenius FRE.DE	Supplier and customer	DE	0.70
Rockwell Medical, Inc. RMTI	Supplier	US	0.65
Renalytix RENX.L	Supplier and customer	GB	0.52
Amgen Inc. AMGN	Supplier	US	0.24
GEE Group, Inc. JOB	Supplier	US	-0.01
Healthcare Realty Trust HR	Supplier	US	-0.04
Berkshire Hathaway B BRK.B	Supplier and customer	US	-0.25
Cantel Medical Corp. CMD	Supplier	US	-0.48
United States	Customer	US	—
Keryx Biopharmaceuticals, Inc. KERX	Supplier	US	—

Similar companies

Companies in the same industry as DaVita

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.